Trial Updates

Novel epilepsy treatment: minimally invasive stimulation 1:46
Novel epilepsy treatment: minimally invasive stimulation
Andreas Schulze-Bonhage
Long-term intermittent use of ubrogepant to treat acute migraines 5:26
Long-term intermittent use of ubrogepant to treat acute migraines
Jessica Ailani
Lessons to be learned from the laquinimod trial for MS 1:50
Lessons to be learned from the laquinimod trial for MS
Gavin Giovannoni
The future of Alzheimer’s disease: aducanumab 2:38
The future of Alzheimer’s disease: aducanumab
John Hardy
Developments in Parkinson’s disease research and PASADENA clinical trial update 3:21
Developments in Parkinson’s disease research and PASADENA clinical trial update
Tiago Outeiro
Beneficial effects of aerobic exercise in slowing Parkinson’s disease progression 4:09
Beneficial effects of aerobic exercise in slowing Parkinson’s disease progression
Terry Ellis
Appraisal of Huntington’s disease clinical trials 2:50
Appraisal of Huntington’s disease clinical trials
Joaquim Ferreira
The 4 Repeat Tauopathy Neuroimaging Initiative 2:00
The 4 Repeat Tauopathy Neuroimaging Initiative
Adam Boxer
The problems arising in ASO clinical trials and future preparations 3:38
The problems arising in ASO clinical trials and future preparations
Joaquim Ferreira
Opicapone shows better motor performance in Parkinson’s disease compared to entacapone 3:37
Opicapone shows better motor performance in Parkinson’s disease compared to entacapone
Joaquim Ferreira
ASO tominersen for Huntington’s disease in Phase III trials 2:20
ASO tominersen for Huntington’s disease in Phase III trials
Edward Wild
Personalized medicine in Parkinson’s disease 2:26
Personalized medicine in Parkinson’s disease
Oscar Gershanik
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic 20:54
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic
Stewart Tepper
Benefit of migraine prevention with erenumab 19:11
Benefit of migraine prevention with erenumab
Stewart Tepper
Pediatric MS: where does research need to move? 1:08
Pediatric MS: where does research need to move?
Tanuja Chitnis
The evolving landscape of migraine treatment and prevention 3:42
The evolving landscape of migraine treatment and prevention
Uwe Reuter
The content of VJNeurology is intended for healthcare professionals